Insmed EBITDA 2010-2025 | INSM

Insmed EBITDA for the quarter ending March 31, 2025 was $-0.242B, a 73.06% increase year-over-year.

  • Insmed 2024 EBITDA was -0.858B, a 24.47% increase from 2023.
  • Insmed 2023 EBITDA was -0.689B, a 56.23% increase from 2022.
  • Insmed 2022 EBITDA was -0.441B, a 34.14% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Insmed EBITDA 2010-2025 | INSM

  • Insmed 2024 EBITDA was -0.858B, a 24.47% increase from 2023.
  • Insmed 2023 EBITDA was -0.689B, a 56.23% increase from 2022.
  • Insmed 2022 EBITDA was -0.441B, a 34.14% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.